Does Rallies track congressional trades in LLY?

Yes. Rallies tracks politician and congressional stock disclosures for LLY, including reported purchases, sales, dates, owners, and trade amounts when available.

Is LLY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for LLY. It does not provide personalized investment advice.

LLY (Eli Lilly) Stock Analysis - Politician Trades

Eli Lilly (LLY) is a publicly traded Healthcare sector company. As of May 20, 2026, LLY trades at $1,017.13 with a market cap of $881.12B and a P/E ratio of 43.77. LLY moved -0.53% today. Year to date, LLY is -5.46%; over the trailing twelve months it is +35.27%. Its 52-week range spans $623.78 to $1,133.95. Analyst consensus is strong buy with an average price target of $1,262.85. Rallies surfaces LLY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded LLY stock?

Recent politician trading activity in LLY includes disclosures from David Taylor, Angus King, David Taylor, David Taylor, and Markwayne Mullin. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

LLY Key Metrics

Key financial metrics for LLY
Metric	Value
Price	$1,017.13
Market Cap	$881.12B
P/E Ratio	43.77
EPS	$23.00
Dividend Yield	1.73%
52-Week High	$1,133.95
52-Week Low	$623.78
Volume	2.02M
Avg Volume	0
Revenue (TTM)	$65.18B
Net Income	$20.64B
Gross Margin	83.04%

Congressional Trades in LLY

David Taylor purchase LLY on Feb 26, 2026 (amount: $15.00K).
Angus King sale LLY on Feb 13, 2026 (amount: $15.00K) for Spouse.
David Taylor sale LLY on Feb 9, 2026 (amount: $15.00K).
David Taylor sale LLY on Jan 16, 2026 (amount: $15.00K).
Markwayne Mullin purchase LLY on Dec 29, 2025 (amount: $50.00K) for Joint.

Latest LLY News

Eli Lilly Sues Church Leaders Over $200M Trulicity Rebate Fraud — May 20, 2026
Supreme Court Upholds Qui Tam Suits and Zepbound Trails Wegovy 1.5x — May 18, 2026
Lilly Commits $50M to UNICEF Partnership, Launches Oral GLP-1 Pill Foundayo — May 14, 2026
Foundayo Regains Only 0.9 kg in 52 Weeks; Zepbound MTD Preserves 100% Loss — May 12, 2026
Alzheimer’s Blood Test Wins CE Mark as Obesity IPO Targets Lilly’s GLP-1 Lead — May 12, 2026

Recent LLY Insider Trades

LILLY ENDOWMENT INC sold 895 (~$971.17K) on Jan 7, 2026.
LILLY ENDOWMENT INC sold 7.68K (~$8.35M) on Jan 7, 2026.
LILLY ENDOWMENT INC sold 1.07K (~$1.16M) on Jan 7, 2026.

LLY Analyst Consensus

22 analysts cover LLY: 0 strong buy, 19 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $1,262.85.

Common questions about LLY

Which politicians traded LLY stock?: Recent politician trading activity in LLY includes disclosures from David Taylor, Angus King, David Taylor, David Taylor, and Markwayne Mullin. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in LLY?: Yes. Rallies tracks politician and congressional stock disclosures for LLY, including reported purchases, sales, dates, owners, and trade amounts when available.
Is LLY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for LLY. It does not provide personalized investment advice.